Lab
Norinda Caceres
Norinda Caceres was paid $305K by Medicaid between Jan 2018 and Aug 2024, across 28 billing codes. Its largest line is 84443, Thyroid stimulating hormone (TSH) — 17% of everything it billed.
33Billing provider infoNORINDA CACERES
MOCA, PUERTO RICO 00676
MOCA, PUERTO RICO 00676
33aNPI1376603670assigned 12/10/2006
33bProvider typeClinical Medical Laboratory
28Total paid$305K
24GClaims25,581
24DCodes billed28
24AFirst – last monthJan 2018 – Aug 2024
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 3,884 | $36K | |
| 2019 | 2,643 | $25K | |
| 2020 | 2,629 | $35K | |
| 2021 | 4,560 | $66K | |
| 2022 | 5,489 | $76K | |
| 2023 | 4,227 | $45K | |
| 2024incomplete | 2,149 | $23K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 84443 | Thyroid stimulating hormone (TSH) | 17% | 3,232 | 3,130 | $53K |
| 80061 | Lipid panel | 14% | 3,226 | 3,132 | $42K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 12% | 5,007 | 4,649 | $38K |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | 12% | 886 | 809 | $36K |
| 80053 | Comprehensive metabolic panel | 9.3% | 2,806 | 2,698 | $28K |
| G2023 | Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | 7.7% | 1,048 | 946 | $24K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | 5.3% | 341 | 324 | $16K |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | 4.3% | 483 | 473 | $13K |
| 81000 | 4.0% | 3,906 | 3,735 | $12K | |
| 83036 | Hemoglobin; glycosylated (A1C) | 3.8% | 1,207 | 1,176 | $12K |
| 82274 | 2.8% | 560 | 549 | $8K | |
| 80048 | Basic metabolic panel (calcium, ionized) | 2.6% | 953 | 910 | $8K |
16 more codes
| 86790 | 1.3% | 300 | $4K | |
| 82044 | <1% | 481 | $2K | |
| 82570 | <1% | 291 | $1K | |
| 86701 | <1% | 156 | $1K | |
| U0002 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc | <1% | 24 | $1K |
| 84439 | <1% | 121 | $1K | |
| 87088 | <1% | 84 | $678.41 | |
| G0328 | Colorectal cancer screening; fecal occult blood test, immunoassay, 1-3 simultaneous | <1% | 33 | $521.18 |
| 86738 | <1% | 30 | $459.04 | |
| 85651 | <1% | 122 | $405.33 | |
| 87275 | <1% | 32 | $358.26 | |
| 36415 | Collection of venous blood by venipuncture | <1% | 103 | $354.45 |
| 87276 | <1% | 31 | $348.18 | |
| 82947 | <1% | 74 | $265.71 | |
| 82607 | <1% | 15 | $224.57 | |
| 86592 | <1% | 29 | $119.12 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialCACERES, NORINDA (EMPLOYER)